Altay Therapeutics, Inc.
StreetZero Signal 79
About Altay Therapeutics, Inc.
Altay Therapeutics is a biotechnology company that develops small molecule therapeutics targeting transcription factors to treat chronic inflammatory diseases, neuromuscular disorders, and cancer. The company is headquartered in San Carlos, California. It has received support from grants and investors including Y Combinator.
LATEST FUNDINGPrivate Placement
$15.7M
Announced 2026-10-02
TOTAL RAISED$3.15M
IN THE NEWS
- 🔗 Altay Therapeutics Valuation & Funding History | Caplight
- 🔗 Altay Therapeutics - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- 🔗 Altay Therapeutics Company Overview, Contact Details & Competitors | LeadIQ
- 🔗 Altay Therapeutics 2026 Company Profile: Valuation, Funding & Investors | PitchBook
- 🔗 Innovating Therapeutics for Unmet Medical Need
EMPLOYEES1-10
FOUNDED2019
HQSan Carlos, CA, United States
Industry
Biotechnology
Tags
BiotechnologyTherapeuticsGrant
Investors
Key highlights
- Developed small molecule therapeutics targeting transcription factors.
- Received $3M financing from SOLVE FSHD in 2022.
- Awarded Golden Ticket by Astellas Therapeutics in Dec 2023.
- Selected as finalist for $10M FSHD Bonus Prize in 2025.
- Raised total funding of around $3.15M according to PitchBook.
Ask StreetZero about Altay Therapeutics, Inc.
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account